Literature DB >> 18374091

Gene expression profiling of human pancreatic islets undergoing a simulated process of instant blood-mediated inflammatory reaction.

A Jackson1, C McWilliams, E Kaizer, D Chaussabel, C Glaser, H Noguchi, S Matsumoto, M F Levy, B Naziruddin.   

Abstract

OBJECTIVE: Islet cell transplantation, as a treatment for type 1 diabetes mellitus, has historically required islet infusions from more than one donor organ to achieve insulin independence. Significant islet mass may be destroyed upon infusion due to a yet undefined process known as instant blood-mediated inflammatory reaction (IBMIR). Our objective was to identify gene expression changes in islets undergoing a simulated process of IBMIR.
MATERIALS AND METHODS: Human pancreatic islets were isolated from 2 cadaveric donors and divided into 3 groups each for a total of 18 samples. Group one (n = 3) was treated with autologous sera, group two (n = 3) with allogeneic sera, and group three (n = 3) with type 1 diabetic sera (T1DM). Each group was treated for 3 hours at 37 degrees C. Islets were washed, lysed using TRI reagent, and mRNA was isolated using the Total Prep mRNA isolation kit. Isolated cRNA was used for microarray analysis using Illumina Gene Chips Hu6_v2. GeneSpring GX software was used for statistical analysis. Results were significant at P < .05.
RESULTS: One-way ANOVA statistical analysis of the microarray data revealed that interleukin-11 (IL-11), interleukin-12A (IL-12A), and Ras related associated with diabetes (RRAD) were overexpressed in islets exposed to diabetic sera when normalized to autologous control (P < .01). Under the same conditions, islet cells exposed to T1DM serum had down-regulation of IL-1 receptor antagonist (IL-1RN).
CONCLUSION: These findings suggested that T1DM serum elicited an adaptive and innate immune response to the transplanted islet mass making them more susceptible to cytokine-mediated destruction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374091     DOI: 10.1016/j.transproceed.2008.01.021

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  History of the biomedical studies PhD program: a joint graduate program of the Baylor Health Care system and Baylor University.

Authors:  Christine R Morel; Joshua M Horton; Han Peng; Kangling Xu; Sushil K Batra; Jonathan P Miles; Robert R Kane
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

2.  Alleviation of instant blood-mediated inflammatory reaction in autologous conditions through treatment of human islets with NF-κB inhibitors.

Authors:  Mazhar A Kanak; Morihito Takita; Takeshi Itoh; Jeffrey A SoRelle; Shyam Murali; Faisal Kunnathodi; Rauf Shahbazov; Michael C Lawrence; Marlon F Levy; Bashoo Naziruddin
Journal:  Transplantation       Date:  2014-09-15       Impact factor: 4.939

Review 3.  NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP).

Authors:  Klaus H Kaestner; Alvin C Powers; Ali Naji; Mark A Atkinson
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

Review 4.  Prediction and pathogenesis in type 1 diabetes.

Authors:  Anette-G Ziegler; Gerald T Nepom
Journal:  Immunity       Date:  2010-04-23       Impact factor: 31.745

5.  Gene expression changes in human islets exposed to type 1 diabetic serum.

Authors:  Andrew M Jackson; Mazhar A Kanak; Ellen K Grishman; Damien Chaussabel; Marlon F Levy; Bashoo Naziruddin
Journal:  Islets       Date:  2012-07-01       Impact factor: 2.694

6.  Induction of protective genes leads to islet survival and function.

Authors:  Hongjun Wang; Christiane Ferran; Chiara Attanasio; Fulvio Calise; Leo E Otterbein
Journal:  J Transplant       Date:  2011-12-14

7.  A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma.

Authors:  Prasong Khaenam; Darawan Rinchai; Matthew C Altman; Laurent Chiche; Surachat Buddhisa; Chidchamai Kewcharoenwong; Duangchan Suwannasaen; Michael Mason; Elizabeth Whalen; Scott Presnell; Wattanachai Susaengrat; Kimberly O'Brien; Quynh-Ahn Nguyen; Vivian Gersuk; Peter S Linsley; Ganjana Lertmemongkolchai; Damien Chaussabel
Journal:  J Transl Med       Date:  2014-03-11       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.